| No. 22A272 |
|
| Title: |
Novartis Pharmaceuticals Corporation, Applicant v. HEC Pharm Co., Ltd., et al. |
| Docketed: | September 29, 2022 |
| Lower Ct: | United States Court of Appeals for the Federal Circuit |
| Case Numbers: | (2021-1070) |
| Sep 28 2022 | Application (22A272) for a stay, submitted to The Chief Justice. Main Document Lower Court Orders/Opinions Proof of Service |
| Sep 29 2022 | Upon consideration of the application of counsel for the applicant, it is ordered that the mandate of the United States Court of Appeals for the Federal Circuit, case No. 2021-1070, is hereby stayed pending further order of The Chief Justice or of the Court. It is further ordered that a response to the application be filed on or before Wednesday, October 5, 2022, by noon (EDT). |
| Oct 05 2022 | Response to application from respondent HEC Pharm Co., Ltd., et al. filed. Main Document Main Document Proof of Service |
| Oct 07 2022 | Reply of applicant Novartis Pharmaceuticals Corporation filed. Reply Proof of Service |
| Oct 11 2022 | Supplemental letter from applicant filed. Main Document Other |
| Oct 11 2022 | Supplemental letter from respondents filed. Main Document |
| Oct 13 2022 | Application (22A272) referred to the Court. |
| Oct 13 2022 | Application (22A272) for stay of the mandate presented to The Chief Justice and by him referred to the Court is denied. The order heretofore entered by The Chief Justice is vacated. |